# PF-06669571 In Subjects With Idiopathic Parkinson's Disease

> **NCT02565628** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **DRUG:** PF-06669571
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02565628
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-16
- **Primary completion:** 2016-05-13
- **Final completion:** 2016-05-13
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565628, "PF-06669571 In Subjects With Idiopathic Parkinson's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02565628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*